1The First Affiliated Hospital of Hainan Medical College, Hainan, China
2GE HealthCare MR Research, Beijing, China
Presenting Author: Zijing Lin
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Kang M. Chinese guidelines for radiotherapy of nasopharyngeal carcinoma (2022 version Chin J Cancer Prev Treat, 2022, 29(9): 611-622. https://doi.org/10.16073/j.cnki.cjcpt.2022.09.01. [doi]
2. Yang Z, Zuo Q, Liu R, et al. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study. BMC Cancer, 2023, 23(1): 1140. https://doi.org/10.1186/s12885-023-11608-5. [doi]
3. Htet H, Anaghan JRJ, Jaiprakash H, et al. Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis. BMC Cancer, 2025, 25(1): 1-13. https://doi.org/10.1186/s12885-025-13528-y. [doi]
4. Wang Z, Feng M, Zhang J, et al. Radiomics and deep learning in nasopharyngeal carcinoma:a review. IEEE Rev Biomed Eng, 2023. https://doi.org/10.1109/RBME.2023.3269776. [doi]